Tennessee readies for execution of man with working implanted defibrillator
Gov. Bill Lee declined Monday to grant a reprieve, clearing the way for Byron Black's execution after a legal battle and ongoing uncertainty about whether the implantable cardioverter-defibrillator will shock his heart when the lethal drug takes effect.
The nonprofit Death Penalty Information Center said it's unaware of any other cases in which a person on death row made similar claims to Black's about defibrillators or pacemakers. Black's attorneys said they haven't found a comparable case, either.
Lee said the courts have "universally determined that it is lawful to carry out the jury's sentence of execution given to Mr. Black for the heinous murders of Angela Clay and her daughters Lakeisha, age 6, and Latoya, age 9."
The U.S. Supreme Court on Monday rejected Black's appeals. The execution would be Tennessee's second since May, after a pause for five years, first because of COVID-19 and then because of missteps by state corrections officials.
Twenty-seven men have died by court-ordered execution so far this year in the U.S., and nine other people are scheduled to be put to death in seven states during the remainder of 2025. The number of executions this year exceeds the 25 carried out last year and in 2018. It is the highest total since 2015, when 28 people were put to death.
Black's condition
Black, 69, is in a wheelchair, and he has dementia, brain damage, kidney failure, congestive heart failure and other conditions, his attorneys have said.
The implantable cardioverter-defibrillator he has is a small, battery-powered electronic device that is surgically implanted in the chest. It serves as a pacemaker and an emergency defibrillator. Black's attorneys say in order to be sure it's off, a doctor must place a programming device over the implant site, sending it a deactivation command, with no surgery required.
In mid-July, a trial court judge agreed with Black's attorneys that officials must have his device deactivated to avert the risk that it could cause unnecessary pain and prolong the execution. But the state Supreme Court intervened July 31 to overturn that decision, saying the other judge lacked the authority to order the change.
The state has disputed that the lethal injection would cause Black's defibrillator to shock him. Even if shocks were triggered, Black wouldn't feel them, the state said.
Black's attorneys have countered that even if the lethal drug being used, pentobarbital, renders someone unresponsive, they aren't necessarily unaware or unable to feel pain.
Kelley Henry, Black's attorney, said the execution could become a 'grotesque spectacle.'
The legal case also spurred a reminder that most medical professionals consider participation in executions a violation of health care ethics.
Black's case
Black was convicted in the 1988 shooting deaths of his girlfriend Angela Clay, 29, and her two daughters. Prosecutors said he was in a jealous rage when he shot the three at their home. At the time, Black was on work-release while serving time for shooting Clay's estranged husband.
Linette Bell, whose sister and two nieces were killed, recently told WKRN-TV: 'He didn't have mercy on them, so why should we have mercy on him?'
Intellectual disability claim
In recent years, Black's legal team has unsuccessfully tried to get a new hearing over whether he is intellectually disabled and ineligible for the death penalty under U.S. Supreme Court precedent.
His attorneys have said that if they had delayed a prior attempt to seek his intellectual disability claim, he would have been spared under a 2021 state law.
Nashville District Attorney Glenn Funk contended in 2022 that Black is intellectually disabled and deserved a hearing under that 2021 law, but the judge denied it. That is because the 2021 law denies a hearing to people on death row who have already filed a similar request and a court has ruled on it 'on the merits."
In Funk's attempt, he focused on input from an expert for the state in 2004 who determined back then that Black didn't meet the criteria for what was then called "mental retardation.' But she concluded that Black met the new law's criteria for a diagnosis of intellectual disability.
Black also sought a determination by the courts that he is incompetent to be executed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Merging deep tech and biomedical science expertise, ChronicleBio aims to accelerate breakthroughs for millions living with complex chronic conditions
New venture harnesses multi-omic data and AI to develop the largest platform on complex chronic illnesses to drive breakthroughs in POTS, ME/CFS, Long COVID, and other neuroimmune disorders SAN FRANCISCO, Aug. 5, 2025 /PRNewswire/ -- ChronicleBio, a techbio startup focused on radically accelerating insights on neuroimmune disorders, officially launched Tuesday with a bold mission: to build the world's richest, AI-ready data platform for historically overlooked conditions like POTS, ME/CFS, Long COVID, and other complex chronic conditions. ChronicleBio is uniquely led by a founding team that unites elite tech, healthcare, and life sciences: Fidji Simo (Co-founder), current CEO of Instacart and the incoming CEO of OpenAI's applications division, brings deep expertise in consumer-scale technology, product innovation, and health systems transformation. Rohit Gupta (Co-founder & CEO), a biobanking and precision medicine leader who previously oversaw centers at Stanford and UCSF, is the leading scientific and strategic force behind ChronicleBio. Rishi Reddy (Co-founder & Executive Chairman), of Tarsadia Investments, brings an entrepreneurial and venture-backed perspective and a track record in health and life sciences investing. Together, they are tackling a critical gap in biomedical research. ChronicleBio is creating a scalable, ethically driven data ecosystem, integrating clinical, molecular, biospecimen, and patient-reported insights to drive biomarker discovery, patient stratification, and precision therapeutic development. "Entire communities of patients have been ignored for too long, not because their conditions aren't debilitating and prevalent, but because the systems weren't built to understand them," said Fidji Simo, co-founder of ChronicleBio. "ChronicleBio is developing a future where patients can enlist in research, and where the data we collect from them goes directly towards better diagnostics and therapeutics. By building these critical missing datasets and leveraging the massive advances in AI, we aim to accelerate the path to cures." These complex chronic conditions impact nearly 300 million people worldwide, but remain woefully understudied, leaving patients hopeless and without meaningful treatments. It's a disease space desperate for data, and ChronicleBio is offering the scalable solutions to provide it. "Neuroimmune disorders remain some of the most poorly understood in medicine and not for lack of interest, but because the underlying data simply doesn't exist at the scale or structure required for serious breakthroughs," said Rohit Gupta, co-founder and CEO of ChronicleBio. "We're empowering patients and clinicians to get involved in this effort to grow our research-grade biobank and AI-ready data platform so we can close that gap and provide the tools to finally interrogate these diseases with scientific rigor and precision, bringing an end to complex chronic conditions." ChronicleBio partners directly with patients, clinics, and research collaborators to generate longitudinal, multi-modal datasets, including genomics, immune profiling, and real-world outcomes designed for exploration and clinical trial readiness. Its platform is already being used in multiple high-integrity clinics in the U.S. and India, as well as through research collaborations with thousands of patients contributing data and biosamples. "We're creating an ecosystem with global reach, designed not just to generate data, but to fundamentally shift how we discover, develop, and deliver treatments at scale. The opportunity for impact—scientifically, medically, and societally—is enormous," said Rishi Reddy, co-founder and Executive Chairman of ChronicleBio. "We're building the foundational infrastructure for a massive medical need that has been hiding in plain sight." ChronicleBio's founding vision isn't just ambitious. It's personal. Both Simo and Reddy have been diagnosed with at least one of the very conditions the company is focused on researching. Gupta's family also suffers from neuroimmune disorders. The group's world-class expertise is outshined only by its heartfelt determination to rewrite the scientific narrative for the millions of patients overlooked by traditional research and transform lived experience into actionable discovery. ChronicleBio's approach includes: A global biobank platform collecting and connecting data on neuroimmune illnesses A proprietary, AI-ready data engine designed to integrate multi-omic, clinical, and real-world evidence Strategic partnerships with clinics, research consortia, and biotech sponsors looking to unlock hard-to-crack therapeutic areas A decentralized clinical trial network accelerating drug development through real-world access to patients and clinicians For more information, visit or follow ChronicleBio on LinkedIn, X, Instagram, and Facebook. Media Contact:media@ View original content to download multimedia: SOURCE ChronicleBio Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
What to know about Legionnaires' disease, which has sickened dozens in New York City
An outbreak of Legionnaires' disease in New York City has killed two people and sickened 58 since late July. City health officials link the Central Harlem outbreak to cooling towers, structures containing water and a fan that are used to cool buildings. They said 11 of these towers initially tested positive for a type of bacteria that causes Legionnaires' disease, but the problem has been remedied. They urged people in the area with flu-like symptoms to contact a health care provider as soon as possible, especially if they are 50 or older, smoke or have chronic lung conditions. Here's what to know. What is Legionnaires' disease? It's a type of pneumonia caused by Legionella bacteria, which grow in warm water and spread in building water systems. They can be found in places such as showerheads, hot tubs and cooling towers. People often get the disease by inhaling aerosols from contaminated water. Hospital patients can also contract it through contaminated water or ice, and babies can be exposed during water births, health officials said. People don't get it from each other. Symptoms usually develop two days to two weeks after exposure and include cough, fever, headaches, muscle aches and shortness of breath, according to the U.S. Centers for Disease Control and Prevention. How does Legionnaires' disease hurt you and how can you treat it? It's important to be diagnosed quickly and treated with the appropriate antibiotics, health officials said. If untreated, the disease usually worsens during the first week, the World Health Organization said. Complications can include respiratory failure, shock and kidney or multi-organ failure. How can Legionnaires' disease be prevented? People responsible for the safety of buildings and water systems can reduce the threat by taking steps to minimize the growth of the bacteria, the WHO said. For example, they should regularly clean and disinfect cooling towers, maintain an adequate level of chlorine in spa pools and flush unused taps in buildings weekly. There are also steps people can take to reduce the risk of Legionnaires' disease at home. New York state health officials suggest draining garden hoses; following manufacturers' instructions for cleaning and replacing water filters; checking chlorine levels in pools and hot tubs regularly and flushing hot water heaters twice a year. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Solve the daily Crossword
Yahoo
20 minutes ago
- Yahoo
Speed driver Chris Raschke dies attempting to set the land speed record during Utah racing event
A speed driver died while trying to break a record during the Bonneville Speed Week event in Utah on Sunday. Chris Raschke, 60, was driving at 283 miles per hour while trying to set a land speed record at Utah's Bonneville Salt Flats. Unfortunately, he lost control of his vehicle two and a half miles into his run, which led to his passing, according to reports. Medical staff quickly acted on the scene before Raschke succumbed to his injuries. In a statement from the Southern California Timing Association, they revealed that the cause of the incident was still under investigation. "At approximately 3:03 p.m. Mountain Time today, driver Chris Raschke was attempting a speed record and lost control of his land speed vehicle at approximately the 2 1/2 mile," The SCTA stated. "Chris was treated by medical professionals at the scene. Unfortunately, Chris passed away from his injuries." Raschke was part of the Speed Demon team out of Ventura, California and drove the Speed Demon Streamliner — a long, narrow, aerodynamic vehicle made to run at high speeds. According to the team website, he began working in motorsports in the 1980s and has been with the Speed Demon team for 13 years. "At this time, we ask everyone to please respect Chris's family, friends, and the Speed Demon team. We are deeply devastated," the team said in a statement. Aside from the Speed Demon team, the American Hot Rod Foundation also mourned Raschke's death. "To those who knew him on the salt, he was someone who found the perfect balance of friendly and competitive. Never a usual combination and one that speaks to the quality of his character," the association stated. "We send our deepest sympathies to Chris's family and friends." The Southern California Timing Association reported that 18 records were set in a total of 261 runs on Sunday. Seven of the records were achieved by cars and 11 were by motorcycles. Speed Week race director Keith Pedersen said Raschke's death was a huge blow to the community. "It's much more of a camaraderie and community, and that builds a lot of friendships and trust," Pedersen told KUTV. "He's a big part of it, and he will be sorely missed." Speed Week will continue at the Bonneville Salt Flats through Friday, August 8.
